Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.29
(-3.33%)
AUD 0.29
(-3.33%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.10 AUD | -34.01% |
| 2023 | -0.07 AUD | -19.04% |
| 2022 | -0.06 AUD | 27.41% |
| 2021 | -0.09 AUD | -156.25% |
| 2020 | -0.03 AUD | -15.07% |
| 2019 | -0.03 AUD | -48.98% |
| 2018 | -0.02 AUD | 49.87% |
| 2017 | -0.04 AUD | 54.11% |
| 2016 | -0.09 AUD | -531.11% |
| 2015 | -0.01 AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 FY | - AUD | -34.01% |
| 2024 Q2 | -0.04 AUD | 0.0% |
| 2024 Q4 | -0.05 AUD | 0.0% |
| 2023 Q2 | -0.05 AUD | 0.0% |
| 2023 Q4 | -0.02 AUD | 0.0% |
| 2023 FY | - AUD | -19.04% |
| 2022 Q4 | -0.03 AUD | 0.0% |
| 2022 FY | - AUD | 27.41% |
| 2022 Q2 | -0.04 AUD | 0.0% |
| 2021 Q2 | -0.08 AUD | 0.0% |
| 2021 FY | - AUD | -156.25% |
| 2021 Q4 | -0.02 AUD | 0.0% |
| 2020 FY | - AUD | -15.07% |
| 2020 Q4 | -0.02 AUD | 0.0% |
| 2020 Q2 | -0.01 AUD | 0.0% |
| 2019 FY | - AUD | -48.98% |
| 2019 Q2 | -0.01 AUD | 0.0% |
| 2019 Q4 | -0.02 AUD | 0.0% |
| 2018 Q2 | -0.01 AUD | 0.0% |
| 2018 FY | - AUD | 49.87% |
| 2018 Q4 | -0.01 AUD | 0.0% |
| 2017 Q4 | -0.02 AUD | 0.0% |
| 2017 FY | - AUD | 54.11% |
| 2017 Q2 | -0.02 AUD | 0.0% |
| 2016 FY | - AUD | -531.11% |
| 2016 Q4 | -0.01 AUD | 0.0% |
| 2016 Q2 | -0.10 AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | -0.01 AUD | 0.0% |
| 2015 Q4 | -0.01 AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |